This inventor holds 41 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Anticancer Agents. Top assignees: National Science Council, China Medical University, Taipei Medical University. Active years: 1992-2022.
Location History:
- Taipei 106, TW (2003)
- Taipei, TW (1992 - 2022)
Company Filing History:
9 out of 544 
6 out of 110 
6 out of 145 
Years Active: 1992-2022
Areas of Expertise:
Title: Che-Ming Teng: A Pioneer in Pharmaceutical Innovations
Introduction: Che-Ming Teng, based in Taipei, Taiwan, is a prominent inventor with an impressive portfolio of 41 patents. His work primarily focuses on innovative pharmaceutical compounds aimed at treating critical medical conditions. With a strong academic and professional background, Teng has made significant contributions to the fields of biochemistry and medicinal chemistry.
Latest Patents: Among his latest patents, Teng has developed heat shock protein 90 inhibitors. This invention relates to aromatic compounds that help in treating medical conditions associated with Heat Shock Protein-90 (HSP90), particularly cancer. The compounds of formula (I) and their pharmaceutical compositions represent a notable advancement in cancer treatment methodologies. Additionally, Teng has patented hydroxamic acid compounds that act as histone deacetylase 6 inhibitors. This patent outlines the pharmaceutical composition containing such compounds and elaborates on methods for treating conditions linked to histone deacetylase 6 dysregulation.
Career Highlights: Throughout his career, Che-Ming Teng has been affiliated with esteemed institutions such as the National Science Council and Yung Shin Pharmaceutical Industries Co., Ltd. His work has been instrumental in fostering innovation in drug discovery and therapeutic development, further establishing him as a leading figure in his field.
Collaborations: Collaborating with talented individuals, Teng has worked alongside coworkers such as Sheng-Chu Kuo and Shiow-Lin Pan. These collaborations have enhanced his research output and fostered the development of groundbreaking innovations in pharmaceuticals.
Conclusion: Che-Ming Teng's contributions to pharmaceutical innovations and his extensive patent portfolio underscore his vital role in advancing medical research. His latest inventions in the realm of therapeutic compounds illustrate the potential to significantly impact treatment options for patients with challenging medical conditions. As his career progresses, Teng will undoubtedly continue to play a crucial role in the development of innovative therapies in the pharmaceutical industry.